Fibroblast Invasive Migration into Fibronectin/Fibrin Gels Requires a Previously Uncharacterized Dermatan Sulfate-CD44 Proteoglycan

Journal of Investigative Dermatology

Volumn 122, Issue 2, 2004, Pages 266-277

  Clark, Richard A F ^a   Lin, Fubao ^a   Greiling, Doris ^a   An, Jianqang ^a   Couchman, John R ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

CD 44; Cell migration; Chondroitin sulfate; Collagen; Fibroblast; Glycosaminoglycan; Heparan sulfate; Wounds

Indexed keywords

4 NITROPHENYL BETA DEXTRO PYRANOSIDE; CD44V ANTIGEN; CELL SURFACE RECEPTOR; CHONDROITIN SULFATE; CORE PROTEIN; DERMATAN SULFATE; FIBRONECTIN; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HERMES ANTIGEN; PLATELET DERIVED GROWTH FACTOR; PROTEOGLYCAN; PYRANOSIDE; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; BINDING AFFINITY; CELL MIGRATION; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 1442299084     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202X.2004.22205.x     Document Type: Article

References (74)

1. Antsee DJ, Gardner B, Spring FA, et al: New monoclonal antibodies CD44 and CD58: Their use to quantify CD44 and CD58 on normal human erythrocytes and to compare the distribution of CD44 and CD58 in human tissue. Immunology 74:197-205, 1991
2. Arch R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich P, Zoller M: Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science (Washington, DC) 257:682-685, 1992
3. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B: CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303-1313, 1990
4. Barkalow FJ, Schwarzbauer JE: Localization of the major heparin-binding site in fibronectin. J Biol Chem 266:7812-7818, 1991
5. Barkalow FJ, Schwarzbauer JE: Interactions between fibronectin and chondroitin sulfate are modulated by molecular context. J Biol Chem 269:3957-3962, 1994
6. Bartolazzi A, Nocks A, Aruffo A, Spring F, Stamenkovic I: Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J Cell Biol 132:1199-1208, 1996
7. Bennett KL, Jackson DG, Simon JC, et al: CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 128:687-698, 1995
8. Bloor BK, Jelvagharan M, White KN, Odell EW: Characterization of CD44 splicing pattern in normal keratinocytes, dysplastic and squamous carcinoma cell lines. Int J Oncol 18:1053-1059, 2001
9. Borland G, Ross JA, Guy K: Forms and functions of CD44. Immunology 93:139-148, 1998
10. Brown TA, Bouchard T, St John T, Wayner E, Carter WG: Human keratinocytes express a new CD44 core protein (CD44E) as a heparin-sulfate intrinsic membrane proteoglycan with additional exons. J Cell Biol 113:207-221, 1991
11. Clark EA, Brugge JS: Integrins and signal transduction pathways: The road taken. Science 268:233-239, 1995
12. Clark RAF: Wound repair. Overview and general considerations. In: Clark RAF (ed). Molecular and Cellular Biology of Wound Repair. New York: Plenum, 1996; 3-50
13. Clark RAF, Lin F, Greiling D, Khan AJ, Schwarzbauer J: Fibroblast migration on fibronectin requires three distinct functional domains. J Invest Dermatol 121:695-705, 2003
14. Couchman JR, Caterson B, Christner JE, Baker JR: Mapping by monoclonal antibody detection of glycosaminoglycans in connective tissue. Nature 307:650-652, 1984
15. Couchman JR, Kapoor R, Sthanam M, Wu R-R: Perlecan and basement membran-chondroitin sulfate proteoglycan (Bamacan) are two basement membrane chondroitin/dermatan sulfate proteoglycans in the Engelbreth-Holm-Swarm tumor matrix. J Biol Chem 271:9595-9602, 1996
16. Culty M, Miyake K, Kincade PW, Silorski E, Butcher EC, Underhill C: The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol 111:2765-2774, 1990
17. Denhom EM, Cauchon E, Poulin C, Silver PJ: Inhibition of human dermal fibroblast proliferation by removal of dermatan sulfate. Eur J Parm 400:145-153, 2000
18. Deutsch DG, Mertz ET: Plasminogen: Purification from human plasma by affinity chromatography. Science 170:1095-1096, 1970
19. Dougherty GJ, Lansdorp PM, Cooper DL, Humphries RK: Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells. J Exp Med 174:1-5, 1991
20. Ehnis T, Dieterich W, Bauer M, Lampe B, Schuppan D: A chondroitin/dermatan sulfate form of CD44 is a receptor for collagen XIV (undulin). Exp Cell Res 229:388-397, 1996
21. Faassen AE, Schrager JA, Klein DJ, Oegema TR, Couchman JR, McCarthy JB: A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. J Cell Biol 116:521-531, 1992
22. Faassen AE, Mooradian DL, Tranquillo RT, Dickinson RB, Letourneau PC, Oegema TR, McCarthy JB: Cell surface CD44-related chondroitin sulfate proteoglycan is required for transforming growth factor-β-stimulated mouse melanoma cell motility and invasive behavior on type I collagen. J Cell Sci 105:501-511, 1993
23. Gailit J, Clark RAF: Studies in vitro on the role of αv and β1 integrins in the adhesion of human dermal fibroblasts to provisional matrix proteins fibronectin, vitronectin, and fibrinogen. J Invest Dermatol 106:102-108, 1996
24. Gailit J, Pierschbacher M, Clark RAF: Expression of functional α4β1 by human dermal fibroblasts. J Invest Dermatol 100:323-328, 1993
25. Gailit J, Clarke C, Newman D, Tonnesen MG, Mosesson MW, Clark RAF: Human fibroblasts bind directly to fibrinogen at RGD sites through integrin αvβ3. Exp Cell Res 232:118-126, 1997
26. Goodison S, Tarin D: Clinical implications of anomalous CD44 gene expression in neoplasia [In Process Citation]. Front Biosci 3:89-E109, 1998
27. Greenfield B, Wang W-C, Marquardt H, Piepkorn M, Wolff EA, Aruffo A, Bennett KL: Characterization of the heparan sulfate and chondroitin sulfate assembly sites in CD44. J Biol Chem 274:2511-2517, 1999
28. Greiling D, Clark RAF: Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. J Cell Sci 110:861-870, 1997
29. Gumbiner BM: Cell adhesion. The molecular basis of tissue architecture and morphogenesis. Cell 84:345-358, 1996
30. He Q, Lesley J, Hyman R, Ishihara K, Kincade PW: Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition. J Cell Biol 119:1711-1719, 1992
31. Heldin C-H, Westermark B: Role of platelet-derived growth factor in vivo. In Clark RAF (ed). Molecular and Cellular Biology of Wound Repair. New York: Plenum, 1996; p 249-274
32. Hendin BN, Longaker MT, Finkbeiner WE, Roberts LJ, Stern R: Hyaluronic acid deposition in cardiac myxomas: Localization using a hyaluronate-specific binding protein. Am J Cardiovasc Pathol 3:209-215, 1990
33. Henke C, Bitterman P, Roongta U, Ingbar D, Polunovsky V: Induction of fibroblast apoptosis by anti-CD44 antibody: Implications for the treatment of fibroproliferative lung disease. Am J Pathol 149:1639-1650, 1996a
34. Henke CA, Roongta U, Mickelson DJ, Knutson JR, McCarthy JB: CD44-related chondrotin sulfate proteoglycan, a cell surface receptor implicated with tumor cell invasion, mediates endothelial cell migration on fibrinogen and invasion into a fibrin matrix. J Clin Invest 97:2541-2552, 1996b
35. Higaki M, Sakaue H, Ogawa W, Kasuga M, Shimokado K: Phosphatidylinositol 3-kinase-independent signal transduction pathway for platelet-derived growth factor-induced chemotaxis. J Biol Chem 271:29342-29346, 1996
36. Huttenlocher A, Ginsberg MH, Horwitz AF: Modulation of cell migration by integrin-mediated cytoskeletal linkages and ligand-binding affinity. J Cell Biol 134:1551-1562, 1996
37. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11-25, 1992
38. Iida J, Meijne AML, Spiro RC, Roos E, Furcht LT, McCarthy JB: Spreading and focal contact formation of human melanoma cells in response to the stimulation of both melanoma-associated proteoglycan (NG2) and α4β1 integrin. Cancer Res 55:2177-2185, 1995
39. Iida J, Meijine AML, Knutson JR, Furcht LT, McCarthy JB: Cell surface chondroitin sulfate proteoglycans in tumor cell adhesion, motility and invasion. Semin Cancer Biol 7:155-162, 1996
40. Jackson DG, Buckley J, Bell JI: Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem 267:4732-4739, 1992
41. Jackson DG, Bell JI, Dickinson R, Timans J, Shields J, Whittle N: Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 128:673-685, 1995
42. Jalkanen S, Jalkanen M: Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol 116:817-825, 1992
43. Jalkanen S, Bargatze R, de los Toyos J, Butcher EC: Lymphocyte recognition of high endothelium: Antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol 105:983-990, 1987
44. Knox P, Crooks S, Rimmer CS: Role of fibronectin in the migration of fibroblasts into plasma clots. J Cell Biol 102:2318-2323, 1986
45. Knutson JR, Iida J, Fields GB, McCarthy JB: CD44/chondroitin sulfate proteoglycan and α2β1 integrin mediate human melanoma cell migration in type IV collagen and invasion of basement membranes. Mol Cell Biol 7:383-396, 1996
46. Koopman G, Heider KH, Horst E, et al: Activated human lymphocytes and aggressive non-Hodgkins lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 177:897-904, 1993
47. Lesley J, Hyman R, English N, Catterall JB, Turner GA: CD44 in inflammation and metastasis. Glycoconj J 14:611-622, 1997
48. Levesque MC, Haynes BF: In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression. J Immunol 156:1557-1565, 1996
49. Liao H-X, Levesque MC, Patton K, et al: Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies. J Immunol 151:6490-6499, 1993
50. Liao H-X, Lee DM, Levesque MC, Haynes BF: N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding. J Immunol 155:3938-3945, 1995
51. Liu J, Fitzli D, Liu M, Tseu I, Caniggia I, Rotin D, Post M: PDGF-induced glycosaminoglycan synthesis is mediated via phosphatidylinositol 3-kinase. Am J Physiol 274:702-L713, 1998
52. Mackay CR, Terpe HJ, Stauder R, Marston WL, Stark H, Gunthert U: Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 124:71-82, 1994
53. McCarthy JB, Hagen ST, Furcht LT: Human fibronectin contains distinct adhesion-and motility-promoting domains for metastatic melanoma cells. J Cell Biol 103:179-188, 1986
54. McCarthy JB, Iida J, Furcht LT: Mechanisms of parenchymal cell migration into wounds. In: Clark RAF (ed). Molecular and Cellular Biology of Wound Repair. New York: Plenum, 1996; p 391-426
55. McClain SA, Simon M, Jones E, et al: Mesenchymal cell activation is the rate-limiting step of granulation tissue induction. Am J Pathol 149:1257-1270, 1996
56. Messadi DV, Bertolami CN: CD44 and hyaluronan expression in human cutaneous scar fibroblasts. Am J Pathol 142:1041-1049, 1993
57. Milstone LM, Hough-Monroe L, Kugelman LC, Bender JR, Haggerty JG: Epican, a heparan/chondroitin sulfate proteoglycan form of CD44, mediates cell-cell adhesion. J Cell Sci 107:3183-3190, 1994
58. Naot D, Sionov RV, Ish-Shalom D: CD44: Structure, function, and association with the malignant process. Adv Cancer Res 71:241-319, 1997
59. Patel DD, Hale LP, Whichard LP, Radcliff G, Mackay CR, Haynes BF: Expression of CD44 molecules and CD44 ligands during human thymic fetal development: Expression of CD44 isoforms is developmentally regulated. Int Immunol 7:277-286, 1995
60. Randolph RK, Simon M: Characterization of retinol metabolism in cultured human epidermal keratinocytes. J Biol Chem 268:9198-9205, 1993
61. Rheinwald JG, Green H: Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells. Cell 6:331-344, 1975
62. Rivadeneira ED, Sauls DL, Yu Y, Haynes BF, Weinberg LB: Inhibition of HIV type 1 infection of mononuclear phagocytes by anti-CD44 antibodies. AIDS Res Hum Retroviruses 11:541-546, 1995
63. Romashkova JA, Makarov SS: NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401:86-90, 1999
64. Schwarz NB: Regulation of chondroitin sulfate synthesis. J Biol Chem 252:6316-6321, 1977
65. Stamenkovic I, Amiot M, Pesando JM, Seed B: A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 56:1057-1062, 1989
66. Stamenkovic I, Aruffo A, Amiot M, Seed B: The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 10:343-348, 1991
67. 2-induced apoptosis of human fibroblasts. FEBS Lett 447:274-276, 1999
68. Svee K, White J, Vaillant P, et al: Acute lung injury fibroblast migration and invasion of a fibrin matrix is mediated by CD44. J Clin Invest 98:1713-1727, 1996
69. Turley EA: Hyaluronan and cell locomotion. Cancer Metastasis 11:21-30, 1992
70. Underhill C: CD44: The hyaluronan receptor. J Cell Sci 103:293-298, 1992
71. Woods A, Couchman JR: Syndecans: Synergistic activators of cell adhesion. Trends Cell Biol 8:189-192, 1998
72. Woods A, Oh ES, Couchman JR: Syndecan proteoglycans and cell adhesion. Matrix Biol 17:477-483, 1998
73. Woods A, Longley RL, Tumova S, Couchman JR: Syndecan-4 binding to the high affinity heparin-binding domain of fibronectin drives focal adhesion formation in fibroblasts. Arch Biochem Biophys 374:66-72, 2000
74. Xu J, Clark RAF: Extracellular matrix alters PDGF regulation of fibroblast integrins. J Cell Biol 132:239-249, 1996